US05348Y1055
US05348Y1055
Avalyn Pharma Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 91.292.000 | 57.121.000 | 59.8% | |
| Operating Income | -91.292.000 | -57.121.000 | 59.8% |
| Pretax Income | -85.204.000 | -49.744.000 | 71.3% |
| Net Income Common Stockholders | -85.204.000 | -49.744.000 | 71.3% |
| -- | -- | -- | |
| -- | -- | -- |